IP Library Granted Patent US 7,211,272
Granted Patent B2
US 7,211,272 · App. 11/006,915 · Granted May 1, 2007

Drug delivery device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,211,272
App. No.
11/006,915
Granted
May 1, 2007
Kind
B2
Abstract

A drug delivery device for placement in the eye includes a drug core comprising a pharmaceutically active agent, and a holder that holds the drug core. The holder is made of a material impermeable to passage of the active agent and includes an opening for passage of the pharmaceutically agent therethrough to eye tissue. The device includes a layer of material permeable to passage of the active agent. In assembling the device, a pin or weight, having a shape similar to the drug core, is used during curing of the permeable material.

Claims (24)

1. A method for making a drug delivery device, comprising:

providing a holder made of a material impermeable to passage of an active agent, said holder being shaped to receive a drug core that includes the active agent;

adding a curable liquid to the holder, and inserting a pin in the holder to displace the curable liquid;

curing the liquid and removing the pin; and

inserting the drug core into the holder.

2. The method of claim 1 , wherein the drug core is shaped similarly as the pin.

3. The method of claim 1 , wherein the holder includes at least one opening for passage of the pharmaceutically agent.

4. The method of claim 1 , further comprising, after insertion of the drug core, covering the drug core with a layer of material.

5. The method of claim 4 , wherein the layer of material includes a suture tab.

6. The method of claim 1 , wherein the impermeable material comprises silicone.

7. The device of claim 1 , wherein the drug core comprises a mixture of the active agent and a matrix material permeable to said active agent.

8. The method of claim 7 , wherein the matrix material comprises polyvinyl alcohol.

9. The method of claim 1 , wherein the curable liquid comprises polyvinyl alcohol.

10. The method of claim 1 , wherein the liquid is cured by heating the device.

11. The method of claim 1 , wherein the holder comprises a cylinder that surrounds the inserted drug core.

12. The method of claim 11 , wherein an end of the cylinder includes at least one opening.

13. The method of claim 1 , wherein the drug core is cylindrical.

14. The method of claim 1 , wherein the drug core is coated with a material permeable to said active agent.

15. The method of claim 1 , further comprising inserting a preformed disc of material in the holder, followed by adding the curable liquid to holder and preformed disc.

16. The method of claim 15 , wherein the holder is cylindrical and the disc is circular.

17. The method of claim 16 , wherein an end of the cylinder includes at least one opening, and the disc covers the at least one opening.

18. The method of claim 15 , wherein the disc is made of a material permeable to the active agent.

19. The method of claim 15 , wherein the disc is made of polyvinyl alcohol.

20. The method of claim 15 , further comprising, after insertion of the drug core, covering the drug core with a layer of material including a suture tab.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Mar 26, 2008
From: BAUSCH & LOMB INCORPORATED; WP PRISM INC.; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; IOLAB CORPORATION; RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC
To: CREDIT SUISSE
Reel/Frame 020733/0765 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2005
From: RENNER, STEVEN B.; JONASSE, MATTHEW
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 015635/0425 →